SPRAGUE JOHN M (Chief Financial Officer) exercised options at T2 BIOSYSTEMS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/20/2024ACC: 0000950170-24-017070
Officer· Chief Financial Officer
Since Jul 2018
+80.00
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
80.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40.00
Price / share
—
Trade value
—
% of position
55.6%
2/20/2024
72.00→112.00
Total
Net shares
+40.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2024 | M · Option Exercise | +40.00 | — | — | 55.6% | 72.00 | 112.00 |
| Total | +40.00 | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stok
40.00 shares
Shares
+40.00
Strike price
Held after
40.00
Exercisable
—
2/20/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stok40.00 shares | 2/20/2024 | A · Award | +40.00 | — | 40.00 |